Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/07/22
End: 12/30/23
Due: 12/30/24
Phase: N/A
Priority: Normal
Start: 12/31/23
End: 12/30/23
Due: 12/30/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV) | NCT04915404 | WPD Pharmaceuticals Sp. z o.o. | user2@example.com | None | 2022-12-07 | 2023-12-30 | 2024-12-30 | - | - | 2025-07-14 |
| A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas | NCT05082493 | WPD Pharmaceuticals Sp. z o.o. | user2@example.com | None | 2023-12-31 | 2023-12-30 | 2024-12-30 | - | - | 2025-07-14 |